Med Vision, a Hangzhou-based digital therapy specialist, has reportedly raised “tens of millions” of renminbi in a Series A+ financing round. The funding was led by Hangzhou Lingxin Enterprise Management Partnership, with a contribution from existing investor Med-Fine Capital. The proceeds will be used to accelerate the commercialization of multiple digital therapies and enhance core technology infrastructure.
Company Overview and Pipeline
Founded in 2016, Med Vision has established itself as a leader in digital therapy solutions. The company boasts a broad product pipeline covering areas such as depression, anxiety, sleep disorders, addiction, and children’s growth. Med Vision has partnered with over 100 hospitals and established specialty Internet hospitals, positioning itself at the forefront of digital health innovation.
Future Outlook
The Series A+ financing round marks a significant milestone for Med Vision, enabling the company to expand its digital therapy offerings and strengthen its core technology capabilities. With robust financial backing and a proven track record in digital health, Med Vision is poised to drive innovation and improve patient outcomes through its comprehensive suite of digital therapies. The company’s strategic focus on commercialization and infrastructure development underscores its commitment to advancing digital health solutions.-Fineline Info & Tech
